Pyridoxal phosphate/Lisinopril
磷酸吡哆醛/赖诺普利
Report date: 2023/11/27 14:59:57
Base Information
Drug NamePyridoxal phosphate/Lisinopril
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes LisinoprilPyridoxal phosphate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedicure Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A